Jonathan Rowe

Jonathan Rowe is a seasoned professional in intellectual property and clinical development, with experience spanning several prominent organizations, including Amarin Corporation and Pfizer. They led portfolio strategy and IP matters at Amarin and Dignity Sciences, where they focused on maximizing the value of intellectual assets and developing commercial strategies. At Pfizer, they held multiple leadership roles, overseeing quality management systems and medical initiatives in cardiovascular research. Currently, Jonathan serves as the Principal and Head of R&D Quality, Operations, and Risk Management at ZS, where they founded the Clinical Development Quality practice area. Jonathan earned their education from the Albert Einstein College of Medicine of Yeshiva University.